Tuesday, March 3, 2026

2nd Edition of International Congress on Materials Science and Nanotechnology (M-Nano 2026)

Presenter:
Paulo Cesar De Morais
Affiliation: Catholic University of BrasΓ­lia
Event: 2nd Edition of International Congress on Materials Science andNanotechnology (M-Nano 2026)
Tittle: Cell viability assays under radiofrequency application modulated by nanomaterials
πŸ“… Conference Dates: November 23–25, 2026
πŸ“ Venue: Singapore & Online
🌐 Website: https://materials.miconferences.com/


πŸ§ͺ Understanding the Research Focus

Nanomaterials are increasingly being explored as modulators of cancer therapies. When combined with external stimuli such as radiofrequency (RF), engineered nanocomposites may significantly enhance therapeutic efficacy while maintaining baseline biocompatibility.

This keynote explores how cell viability assays can quantitatively evaluate antitumor responses when nanomaterials are combined with RF exposure.


πŸ“Š Quantitative Modeling Approach

The presentation applies the Hill model to analyze cell viability data, enabling determination of:

  • Benchmark Dose (BMD)
  • Lethal Dose 50 (LD50)
  • Cooperativity coefficient (E)
  • Dissociation constant (K)

This mathematical framework provides deeper insight into dose–response relationships and nanomaterial-mediated cytotoxicity under RF stimulation.


πŸ”¬ Nanocomposite Strategy

Special emphasis is placed on graphene-based nanocomposites, particularly:

Graphene oxide (GO) functionalized with polyethyleneimine (PEI) and decorated with gold nanoparticles (GO-PEI-Au).

Tumor cell lines evaluated include:

  • LLC-WRC-256
  • B16-F10

Results demonstrate that while GO-PEI-Au exhibits relative biocompatibility in the absence of radiofrequency (nRF), the application of RF dramatically enhances cytotoxicity — increasing tumor cell death by orders of magnitude.


🌟 Key Takeaway

The synergistic combination of radiofrequency therapy with engineered nanomaterials represents a promising direction in cancer treatment.

RF-triggered enhancement of nanocomposite-mediated cytotoxicity supports future translational research, including validation in tumor-bearing animal models.


πŸ‘¨πŸ”¬ About the Speaker

Paulo CΓ©sar De Morais, PhD, is an internationally recognized physicist and nanotechnology researcher with extensive contributions to materials science and biomedical applications. He served as Full Professor of Physics at University of BrasΓ­lia until 2013 and was subsequently appointed Emeritus Professor in 2014. He has also held distinguished international academic appointments, including Visiting Professor at Huazhong University of Science and Technology (2012–2015), Distinguished Professor at Anhui University (2016–2019), and Full Professor at Catholic University of BrasΓ­lia since 2018.He has published more than 500 scientific papers, delivered over 200 international invited talks, holds 15+ patents, and has accumulated more than 13,000 citations.



🌍 Join M-Nano 2026

πŸ”— Abstract Submission: https://materials.miconferences.com/abstract-submission
πŸ”— Register: https://materials.miconferences.com/register
πŸ”— Contact: https://materials.miconferences.com/contact

πŸ“§ materials@mathewsconference.com
πŸ“ž +1 (312) 462-4448
πŸ’¬ WhatsApp: +1 (424) 377-0967

#MNano2026 #MaterialsScience #NanotechnologyConference #AdvancedMaterials #CancerNanomedicine #RadiofrequencyTherapy #GrapheneOxide #GoldNanoparticles #Nanocomposites #CellViability #DoseResponse #HillModel #LD50 #BiomedicalEngineering #TranslationalResearch #Theranostics #OncologyInnovation #NanoMedicine #ScientificResearch #GlobalScience #SingaporeConference #HybridConference #CallForAbstracts #ResearchInnovation #NextGenMaterials

No comments:

Post a Comment

Watch Our Successful 2025 Conference Speaker Presentation | M-Nano 2026

2nd Edition of International Congress on Materials Science and Nanotechnology πŸ“… November 23–25, 2026 πŸ“ Singapore and Online Explore a f...